ArticleTransboundary and emerging diseases2025
Molecular Epidemiology, Lineage Evolutionary Dynamics, and Antigenic Variation Analysis of Type II PRRSV in China During 2024-2025.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Pathogenicity and virulence of PRRSV: From regulated cell death reprogramming landscape and immune subversion to precision vaccinology.Virulence · 2026Review
- Porcine reproductive and respiratory syndrome virus antagonizes the host restriction factor SHFL to sustain viral programmed ribosomal frameshifting and replication.Journal of virology · 2026Article
- Molecular and pathological characteristics of co-infection with PRRSV-1 and PRRSV-2 recombinant strains in a pig farm in Xinjiang, China.BMC veterinary research · 2026Article
- Cross-Protection in PRRSV: Mechanisms, Limitations, and Implications for Vaccine Design.Pathogens (Basel, Switzerland) · 2026Review
- Molecular epidemiology and genetic evolution of PRRSV ORF5 in Sichuan, Southwest China.Frontiers in microbiology · 2026Article
- Recent Advances in Lateral Flow Immunoassay for Rapid Diagnosis of Viral Diseases.Transboundary and emerging diseases · 2026Review
- Longitudinal Molecular Epidemiology and Genomic Evolution of Porcine Reproductive and Respiratory Syndrome Virus in a Large-Scale Swine Production System in Northern China, 2023-2026.Transboundary and emerging diseases · 2026Article
- Numb-Associated Kinases-Mediated AP2M1 Activation Facilitates Porcine Reproductive and Respiratory Syndrome Virus Entry.Transboundary and emerging diseases · 2026Article
- The updated one-step multiplex RT-qPCR method for PRRSV classical strains, highly pathogenic strains and NADC30-like strains.Frontiers in microbiology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) represents one of the major threats to the global swine industry, with its rapid evolution and antigenic variation posing persistent challenges to disease control. Based on 328 clinical samples collected from PRRSV symptomatic (respiratory disorders, reproductive failures, and high fever) pigs across 27 provinces in China during 2024-2025, this study employed open reading frame (ORF) 5 gene sequencing, complete genome sequencing of representative strains from key lineages (including a rapidly spreading NADC30-like Lineage 1.8 strain, a vaccine-related Lineage 8.7 strain, and a genetically distinct Lineage 3 strain), phylogenetic analysis, transmission dynamics analysis, intrahost single nucleotide variant (iSNV) analysis, and recombination detection to systematically reveal the molecular epidemiological characteristics and evolutionary dynamics of type II PRRSV currently circulating in China. The results demonstrated a complex pattern of coexistence among five major lineages of type II PRRSV in China, including Lineage 1.5, Lineage 1.8, Lineage 3, Lineage 5, and Lineage 8.7, with Lineage 1.8 emerging as the predominant circulating strain (48.5% of positive samples), followed by Lineage 1.5 (23.2%), while Lineages 3, 5, and 8.7 showed more restricted geographical distribution. Spatial transmission analysis identified Guangdong and Henan as key transmission nodes, forming "viral exchange centers" connecting northern and southern regions, while Hubei, Shanxi, and Jiangsu have become new viral aggregation sites. Genetic diversity analysis revealed high haplotype diversity (Hd) across all lineages except Lineage 5, with Lineage 5 showing a remarkable 106.6% increase in nucleotide diversity within 1 year, indicating rapid adaptive evolution. Tajima's D test results revealed negative values for most lineages, with Lineage 5 and 8.7 reaching statistical significance, suggesting these viral populations have undergone recent population expansion or directional selection. Multidimensional scaling (MDS) analysis based on genetic distance revealed a potential antigenic divergence between the predominant circulating lineages (1.8 and 3) and current vaccine strains, which may compromise vaccine efficacy. In-depth analysis of three representative genomes revealed complex recombination patterns involving vaccine-related strains and identified the ORF2-ORF3 region as a potential recombination hotspot. The findings of this study provide a scientific basis for understanding the evolutionary mechanisms of type II PRRSV in China and offer important references for formulating targeted control strategies and optimizing vaccine design, which has significant value for ensuring the healthy development of China's swine industry in the post-African swine fever era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.